(Q33536973)

27 July 2017

1 reference

title

Importance of early diagnosis in patients with irritable bowel syndrome (English)

1 reference

27 July 2017

main subject

irritable bowel syndrome

1 reference

Albena D Halpert

1

0 references

language of work or name

English

0 references

publication date

1 March 2010

1 reference

27 July 2017

published in

Postgraduate Medicine

1 reference

27 July 2017

volume

122

1 reference

27 July 2017

issue

2

1 reference

27 July 2017

page(s)

102-111

1 reference

Functional bowel disorders

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Recent developments in the therapy of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Review article: irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Evolving concepts of the pathogenesis of irritable bowel syndrome: to treat the brain or the gut?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Repetitive rectal painful distention induces rectal hypersensitivity in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Use of serum biomarkers in a diagnostic test for irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

AGA technical review on irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Irritable bowel syndrome - an evidence-based approach to diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Abdominal and pelvic surgery in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Irritable bowel syndrome and surgery: a multivariable analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Health status by gastrointestinal diagnosis and abuse history.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

The impact of irritable bowel syndrome on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Towards positive diagnosis of the irritable bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Symptom overlap and comorbidity of irritable bowel syndrome with other conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Clinical practice. Irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

What patients know about irritable bowel syndrome (IBS) and what they would like to know. National Survey on Patient Educational Needs in IBS and development and validation of the Patient Educational Needs Questionnaire (PEQ).

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

The diagnosis of IBS in primary care: consensus development using nominal group technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Family practitioners' attitudes and knowledge about irritable bowel syndrome: effect of a trial of physician education

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Medical and lay views of irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

New clinical method for distinguishing D-IBS from other gastrointestinal conditions causing diarrhea: the LA/IBS diagnostic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Diagnostics of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

A simple method for assessing intestinal inflammation in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Fecal calprotectin as an index of intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

Biomarkers in IBS: when will they replace symptoms for diagnosis and management?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2127

21 January 2018

Identifiers

DOI

10.3810/PGM.2010.03.2127

1 reference

27 July 2017

1 reference